New ‘aerosols measuring instrument’ for medical imaging in hospitals

Posted December 07, 2018 12:28:33Today’s new instrument for measuring oxygen and carbon dioxide concentrations in the lungs has been developed by the American Society for Microbiology (ASM) and is one of a number of tools that the Society is developing to help scientists study the effects of CO2 pollution.

The ASM and the University of Illinois have teamed up to design the new instrument, which uses a scanning electron microscope (SEM) to measure oxygen and other gases in the blood.

The new instrument was developed by scientists at the University at Buffalo (UB) and the U.S. Department of Energy (DOE).

The instrument is a combination of a microelectromechanical system (MEMS) and a microfluidic chamber.

It measures the oxygen content of the blood and the concentration of oxygen-18, oxygen-19, and carbon monoxide.

The instrument is currently in development for use in the clinical setting, but is expected to be used by the end of 2020 to help diagnose CO2-related health problems and detect other symptoms in patients.

The study was published in the journal Environmental Science and Technology.

The work was supported by the National Institutes of Health (NIH) Office of Biological and Environmental Research and the DOE Office of Science.

The research was supported in part by the NASA Early Career Research Award to S.K.D.

S, a DOE Energy Research and Development Career Development Fellowship to A.A.L., a DOE Office for Science Education Fellowship to M.A., and a DOE Career Development Award to R.B.S., a project supported by DOE Office Of Science Education.